82
Views
7
CrossRef citations to date
0
Altmetric
Research Article

In silico study combining QSAR, docking and molecular dynamics simulation on 2,4-disubstituted pyridopyrimidine derivatives

&
Pages 167-174 | Received 01 Mar 2019, Accepted 01 Jul 2019, Published online: 29 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Arwansyah Arwansyah, Abdur Rahman Arif, Gita Syahputra, Sukarti Sukarti & Isman Kurniawan. (2021) Theoretical studies of Thiazolyl-Pyrazoline derivatives as promising drugs against malaria by QSAR modelling combined with molecular docking and molecular dynamics simulation. Molecular Simulation 47:12, pages 988-1001.
Read now

Articles from other publishers (6)

Deblina Rababi & Anish Nag. (2023) Evaluation of therapeutic potentials of selected phytochemicals against Nipah virus, a multi-dimensional in silico study. 3 Biotech 13:6.
Crossref
Rahul Tripathi & Pravir Kumar. (2023) Preliminary study to identify CXCR4 inhibitors as potential therapeutic agents for Alzheimer’s and Parkinson’s diseases. Integrative Biology 15.
Crossref
Md Moinul, Sk Abdul Amin, Tarun Jha & Shovanlal Gayen. (2022) Updated chemical scaffolds of ABCG2 inhibitors and their structure-inhibition relationships for future development. European Journal of Medicinal Chemistry 241, pages 114628.
Crossref
Shahnawaz Ahmad, Md. Imtaiyaz Hassan, Dinesh Gupta, Neeraj Dwivedi & Asimul Islam. (2022) Design and evaluation of pyrimidine derivatives as potent inhibitors of ABCG2, a breast cancer resistance protein. 3 Biotech 12:9.
Crossref
Alexander V. Komkov, Mikhail А. Kozlov, Mikhail А. Prezent, Andrey S. Dmitrenok, Natalya G. Kolotyrkina, Mikhail E. Minyaev & Igor V. Zavarzin. (2022) Synthesis of novel pyrimido[4,5-d]pyrimidine derivatives from 5-acetyl-4-aminopyrimidines. Chemistry of Heterocyclic Compounds 58:4-5, pages 243-250.
Crossref
Mootaz M. Salman, Zaid Al-Obaidi, Philip Kitchen, Andrea Loreto, Roslyn M. Bill & Richard Wade-Martins. (2021) Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases. International Journal of Molecular Sciences 22:9, pages 4688.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.